[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-342894-105":59,"doc-detail-342894-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","t-cells-and-the-pd-1pd-l1-axis-a-lovehate-relationship-in-the-tumor-microenvironment","γδ T cells and the PD-1/PD-L1 axis: a love–hate relationship in the tumor microenvironment","","Gamma delta (γδ) T cells show strong MHC-independent cytotoxicity against many cancer cell types, making them attractive for cancer therapy. Clinical evaluation of γδ T cell amplification and adoptive transfer continues, yet outcomes remain limited because the immunosuppressive tumor microenvironment (TME) weakens their activity. Immune checkpoint-targeting antibodies against inhibitory immune checkpoint molecules are presented as a strategy to counter TME-driven suppression. PD-1/PD-L1 blockade is widely used to preserve αβ T cell responses, while γδ T cells can also infiltrate tumors and affect prognosis. A reciprocal understanding of the PD-1/PD-L1 axis on γδ T cells is therefore essential for improving γδ T cell adoptive transfer and enabling future combination immunotherapies.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/t-cells-and-the-pd-1pd-l1-axis-a-lovehate-relationship-in-the-tumor-microenvironment/342894/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/t-cells-and-the-pd-1pd-l1-axis-a-lovehate-relationship-in-the-tumor-microenvironment/342894.png","ImageObject",300,407,{"name":92,"@type":93},"Violet","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"Why are γδ T cells considered promising for cancer therapy?","Question",{"text":113,"@type":114},"γδ T cells can kill diverse cancer cells with strong cytotoxicity in an MHC-independent manner, which makes them attractive therapeutic candidates.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"What limits the efficacy of γδ T cell adoptive transfer in clinical settings?",{"text":118,"@type":114},"The immunosuppressive tumor microenvironment (TME) reduces therapeutic effectiveness, undermining the activity of transferred γδ T cells.",{"name":120,"@type":111,"acceptedAnswer":121},"How does the PD-1/PD-L1 axis relate to γδ T cells in tumors?",{"text":122,"@type":114},"PD-1/PD-L1 checkpoint inhibitors are used to support antitumor immune responses, but γδ T cells also infiltrate cancers and participate in immunity; therefore, their reciprocal interaction with PD-1/PD-L1 is important for improving therapy.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},342894,1790808966,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":36,"preview_page_count":19,"preview_urls":146},4398048950312,"https://ap-avatar.wpscdn.com/avatar/400002538284de19e3c?_k=1778320343897328908","Liu et al. Journal of Translational Medicine (2024) 22:553  \n[https://doi.org/10.1186/s12967-024-05327-z](https://doi.org/10.1186/s12967-024-05327-z)  \nJournal of Translational Medicine  \n REVIEW Open Access  \nγδ T cells and the PD-1/PD-L1 axis: a love–hate relationship in the tumor microenvironment  \nJian Liu1, Min Wu2, Yifan Yang1, Zixuan Wang3, Shan He3, Xun Tian4* and Hui Wang1,5,6,7*  \nAbstract  \nGamma delta (γδ) T cells demonstrate strong cytotoxicity against diverse cancer cell types in an MHC-independent manner, rendering them promising contenders for cancer therapy. Although amplification and adoptive transfer of γδ T cells are being evaluated in the clinic, their therapeutic efficacy remains unsatisfactory, primarily due to the influence of the immunosuppressive tumor microenvironment (TME) . Currently, the utilization of targeted therapeutic antibodies against inhibitory immune checkpoint (ICP) molecules is a viable approach to counteract the immunosuppressive consequences oftheTME. Notably, PD-1/PD-L1 checkpoint inhibitors are considered primary treatment options for diverse malignancies, with the objective of preserving the response of αβ T cells. However, γδ T cells also infiltrate various human cancers and are important participants in cancer immunity, thereby influencing patient prognosis. Hence, it is imperative to comprehend the reciprocal impact of the PD-1/PD-L1 axis on γδ T cells. This understanding can serve as a therapeutic foundation for improving γδ T cells adoptive transfer therapy and may offera novel avenue for future combined immunotherapeutic approaches.  \nKeywords γδ T cells, PD-1/PD-L1, Immune checkpoints (ICPs), Tumor microenvironment (TME), Immunosuppressive molecules, Immune checkpoint inhibitors (ICIs), Antitumor immunotherapy  \n*Correspondence: Xun Tian [tianxun@zxhospital.com](tianxun@zxhospital.com)[ ](tianxun@zxhospital.com)Hui Wang [huit71@sohu.com](huit71@sohu.com)  \n1 Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China  \n2 Department of Gynecologic Oncology, Women’s Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China  \n3 Department of Pathogen Biology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China  \n4 Department of Obstetrics and Gynecology, Academician Expert Workstation, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430014, Hubei, China  \n5 Cancer Biology Research Center (Key Laboratory of the Ministry of Education), Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China  \n6 Department of Gynecologic Oncology, Zhejiang Provincial Key Laboratory of Precision Diagnosis and Therapy for Major Gynecological Diseases, Women’s Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China  \n7 Zhejiang Provincial Key Laboratory of Precision Diagnosis and Therapy for Major Gynecological Diseases, Women’s Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http","cbCaiu3etpBfvrPA","https://ap.wps.com/l/cbCaiu3etpBfvrPA","pdf",1351413,16,"English","# Background\n## γδ T cell subsets and distribution\n## Functional plasticity and TME-driven roles\n## γδ T17 cells and tumor progression\n# Abstract\n## Therapeutic potential and limitations in the TME\n## PD-1/PD-L1 checkpoint interactions with γδ T cells\n## Implications for combination immunotherapy","[{\"question\":\"Why are γδ T cells considered promising for cancer therapy?\",\"answer\":\"γδ T cells can kill diverse cancer cells with strong cytotoxicity in an MHC-independent manner, which makes them attractive therapeutic candidates.\"},{\"question\":\"What limits the efficacy of γδ T cell adoptive transfer in clinical settings?\",\"answer\":\"The immunosuppressive tumor microenvironment (TME) reduces therapeutic effectiveness, undermining the activity of transferred γδ T cells.\"},{\"question\":\"How does the PD-1/PD-L1 axis relate to γδ T cells in tumors?\",\"answer\":\"PD-1/PD-L1 checkpoint inhibitors are used to support antitumor immune responses, but γδ T cells also infiltrate cancers and participate in immunity; therefore, their reciprocal interaction with PD-1/PD-L1 is important for improving therapy.\"}]","γδ T cells and the PD-1/PD-L1 axis: a love–hate relationship in the tumor microenvironment | PDF",1790048679,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/99b20883ee2b56e10c12597bb1002e98.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5572c82ef1f501c3bfd105a274b4fc01.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dc944c8d7b82f469247c024597800272.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fcca740cc68ba9630f037b6f49c7d079.webp",980,1301]